C86.31

Billable

Subcutaneous panniculitis-like T-cell lymphoma, in remission

HCC Category Mapping

V28HCC 19 — Lymphoma and Other Cancers

0.105

V24HCC 10 — Lymphoma and Other Cancers

0.675

ESRDHCC 10 — Lymphoma and Other Cancers

0.000

RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers

0.000

What This Code Means

A rare lymphoma affecting the fatty tissue under the skin caused by abnormal T-cells that is currently in remission.

Coding Tips

•Only use when remission is explicitly documented
•Confirm remission through clinical assessment or imaging studies

Clinical Significance

Subcutaneous panniculitis-like T-cell lymphoma in remission indicates successful treatment response in this rare cutaneous lymphoma. Alpha-beta phenotype SPTCL has a relatively favorable prognosis and higher remission rates compared to gamma-delta phenotype. Ongoing surveillance is necessary to monitor for relapse and any delayed treatment-related toxicities.

Documentation Requirements

✓Provider must explicitly document remission status with supporting clinical evidence such as resolution of subcutaneous nodules on examination and imaging.
✓The original SPTCL diagnosis confirmation, T-cell receptor phenotype, and surveillance plan should be in the record.
✓Any ongoing treatment or monitoring for hemophagocytic syndrome must be documented.

Commonly Confused Codes

C86.30 (SPTCL not in remission) indicates active disease.Z85.79 (personal history of malignant neoplasm of lymphoid tissue) is only appropriate when disease is cured and not under surveillance.C84.A0 (cutaneous T-cell lymphoma, unspecified site) is a different lymphoma entity.

Code Hierarchy

└C86Other specified types of T/NK-cell lymphoma └C86.3Subcutaneous panniculitis-like T-cell lymphoma └C86.31Subcutaneous panniculitis-like T-cell lymphoma, in remission

└C86.31Subcutaneous panniculitis-like T-cell lymphoma, in remission